Monday, September 08, 2014 1:50:50 PM
As the results of the non-GLP studies conducted at KARD were not announced as completed until December 2013 - it has not been anywhere near 18 months since the finalized quantities of Flucide that would be needed to send to BASi were known. The 18 month figure you tout is inaccurate.
http://www.nanoviricides.com/press%20releases/2013/NanoViricides%20Inc%20Reports%20Excellent%20Safety%20Profile%20of%20Its%20Broad%20Spectrum%20anti%20Influenza%20Drug%20Candidate%20FluCide%20in%20a%20Non%20GLP%20Study.html
Note - Date of December 2, 2013. 9 Months ago.
The existing lab is sufficient to make the Flucide for TOX - it's just suboptimal as the scale of production possible in the old facility is quite a bit lower than the scale of production that will be routine once the new plant is Validated. Because the old facility is sub-optimal, and because the quantities needed are higher than initially expected - it has taken a while.
What evidence is there that work validating the new plant is anything but on schedule? What evidence do you have that there is ANY 'flailing around' going on there other than your unsubstantiated opinion?
Possibly,... but that's just opinion as well.
Recent NNVC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:30:36 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/15/2024 08:44:44 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
FEATURED Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • Nov 18, 2024 11:56 AM
FEATURED North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • Nov 18, 2024 9:00 AM
One World Products Sets New Standards in Sustainability With Strategic Hemp Innovations • OWPC • Nov 18, 2024 7:54 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM